Policy & Regulation
ABL Diagnostics secures clinical research contract worth up to EUR2.7m through 2031
12 June 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Friday that it has signed a multi-year contract with a European pharmaceutical company focused...
WeNatal introduces Iron+ iron and vitamin C supplement
12 June 2026 - Prenatal supplement and lifestyle brand WeNatal announced on Thursday the launch of Iron+, a targeted iron and vitamin C supplement formulated for moments when additional iron support m...
FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer
11 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental...
XtalPi partners with leading biopharma to develop oral small molecule therapeutics for GPCR target
11 June 2026 - XtalPi (HK:2228), a China-based platform in artificial intelligence (AI) and robotics-driven drug discovery, announced on Wednesday a strategic partnership with a prominent internationa...
GlycoNex reports positive Phase III trial results for Denosumab biosimilar SPD8
11 June 2026 - Taiwan-based pharmaceutical company GlycoNex Inc (TWO:4168) announced on Wednesday that the Phase III clinical trial for SPD8, a Denosumab biosimilar co-developed with Mitsubishi Gas Ch...
Orionis Biosciences and Novartis form collaboration to advance molecular glue drug discovery
10 June 2026 - Orionis Biosciences, a privately held, clinical-stage life sciences company, announced on Wednesday that it has entered into a multi-year strategic collaboration with Swiss pharmaceutic...